Children's Oncology Group

Futó vizsgálatok

• Toboroz

  Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

  NCT07437963· 1/2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group

  NCT01117168· Children's Oncology Group· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok1 toboroz
• Neuroblasztóma1 toboroz

Lezárt vizsgálatok

• Lezárult

  Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

  NCT02470091· 2. fázis· Children's Oncology Group· Forrás

• Lezárult

  Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma

  NCT01236560· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

  NCT00379340· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

  NCT00352534· 3. fázis· Children's Oncology Group· Forrás